1. Surgical treatment and prognosis of esophageal cancer after distal gastrectomy.
- Author
-
Lihui Wu, Zhifei Xu, Xuewei Zhao, Jianqiu Li, Yaochang Sun, Wu, Lihui, Xu, Zhifei, Zhao, Xuewei, Li, Jianqiu, and Sun, Yaochang
- Subjects
- *
GASTRECTOMY , *ESOPHAGEAL cancer , *ESOPHAGEAL surgery , *GASTROINTESTINAL diseases , *CANCER diagnosis , *HEALTH outcome assessment , *ADENOCARCINOMA , *COMPARATIVE studies , *ESOPHAGEAL tumors , *RESEARCH methodology , *MEDICAL cooperation , *PROGNOSIS , *RESEARCH , *STOMACH , *STOMACH tumors , *SURGICAL complications , *SURVIVAL , *EVALUATION research , *KAPLAN-Meier estimator , *SECONDARY primary cancer ,PEPTIC ulcer surgery ,DIGESTIVE organ surgery - Abstract
Background: The purpose of the present study was to explore the clinicopathological characteristics and operative therapeutic efficacy of thoracic esophageal cancer after gastrectomy and compare with those without gastrectomy.Methods: From January 2000 to June 2007, 28 esophageal cancer patients with a history of distal gastrectomy underwent subtotal esophagectomy. Vascularized pedicle colonic conduit was most commonly used for esophageal substitution. Six hundred seventeen patients without a history of gastrectomy treated in the same period form the control group. After the operation, pathological characteristic, tumor staging, and survival statistics were analyzed.Results: Of those patients with esophageal cancer associated with gastric remnant, the majority were male. There was an average of 16.5 years for diagnosing esophageal cancer from the initial partial gastrectomy, 75% (21/28) of them were patients with Billroth I anastomosis. The proportion of lower-third tumors in patients after gastrectomy (12 of 28 patients, 43%) was significantly higher compared with that of the patients with intact stomachs (124 of 617 patients, 20%; P = 0.004). After surgical treatment, the overall 1-, 3-, and 5-year survival rates of gastrectomized and nongastrectomized patients were 100%, 35.00%, and 23.33% versus 98.93%, 59.42%, and 30.85% in stages I-II and 80.00%, 30.00%, and 0% versus 98.59%, 62.03%, and 21.03% in stages III-IV. The log rank test of equality of survival distribution for the gastrectomized vs nongastrectomized patients was not significant in stages I-II (P = 0.5692) but was significant in stages III-IV (P = 0.0166).Conclusions: The patients with partial gastrectomy for more than 5 years, having upper gastrointestinal symptoms, should be considered having the risk of esophageal cancer associated with gastric remnant. For patients with a history of distal gastrectomy, a vascularized pedicle colonic conduit was most commonly used for esophageal substitution. Surgical efficacy was similar with the no-gastrectomy group in early stages I-II of esophageal cancer associated with gastric remnant but was lower compared with the no-gastrectomy group in stages III-IV. So, early diagnosis and an aggressive surgical approach may be crucial to achieve better outcomes for esophageal cancer patients with gastrectomy. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF